Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
---|
02/16/2012 | US20120041024 Quinolyl amines as kinase inhibitors |
02/16/2012 | US20120041023 Small molecule activators of mitochondrial function |
02/16/2012 | US20120041017 Pyridocarbazole type compounds and applications thereof |
02/16/2012 | US20120041010 Pharmaceutical combination of (e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl] (3r,5s)-3,5-dihydroxyhept-6-enoic acid and candesartan |
02/16/2012 | US20120040997 Vinyl-aryl derivatives for inflammation and immune-related uses |
02/16/2012 | US20120040994 THERAPEUTIC AGENT FOR GLAUCOMA COMPRISING Rho KINASE INHIBITOR AND PROSTAGLANDIN |
02/16/2012 | US20120040987 Derivatives of 6-(6-nh-substituted-triazolopyridazine-sulfanyl) benzothiazoles and benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as met inhibitors |
02/16/2012 | US20120040964 N-substituted piperidines and their use as pharmaceuticals |
02/16/2012 | US20120040956 Inhibitors of hif-1 protein accumulation |
02/16/2012 | US20120040933 9-(piperazinylalkyl) carbazoles as bax-modulators |
02/16/2012 | US20120040923 Stable s-adenosyl-l-methionine |
02/16/2012 | US20120040897 Novel derivatives of acyl cyanopyrrolidines |
02/16/2012 | US20120040884 Methods and Reagents for Treatment and Diagnosis of Vascular Disorders and Age-Related Macular Degeneration |
02/16/2012 | US20120040014 LIPID Supplements for Maintaining Health and Treatment of Acute and Chronic Disorders |
02/16/2012 | US20120040012 Therapeutic stem cell nutrient composition and uses thereof |
02/16/2012 | US20120040007 Serine palmitoyltransferase inhibitors for preventing and delaying retinitis pigmentosa |
02/16/2012 | US20120039986 Compositions and methods for sirna inhibition of angiopoietin 1 and 2 and their receptor tie2 |
02/16/2012 | US20120039982 Bio-Sheet for Eye Tissue Repair |
02/16/2012 | US20120039927 Use of extracts of pezizaceae in the prevention and/or treatment of senile cataracts |
02/16/2012 | US20120039913 Selective Histamine H4 Receptor Antagonists for the Treatment of Vestibular Disorders |
02/16/2012 | US20120039911 Cd93 or use of soluble fragment thereof |
02/16/2012 | US20120039896 Method for inhibiting cellular activation by insulin-like growth factor-1 |
02/16/2012 | US20120039883 Detection and diagnosis of inflammatory disorders |
02/16/2012 | US20120039839 Hypoxia Induced Mitogenic Factor |
02/16/2012 | US20120039801 SPARC binding peptides and uses thereof |
02/16/2012 | CA2843684A1 Compositions, kits and methods for treatment of complement-related disorders |
02/16/2012 | CA2807858A1 Injectable pharmaceutical composition for preventing, stabilising and/or inhibiting pathological neovascularization-related conditions |
02/16/2012 | CA2807628A1 Methods and pharmaceutical compositions for the treatment of an ocular disease in a subject |
02/15/2012 | EP2418279A1 Injectable pharmaceutical composition for preventing, stabilising and/or inhibiting pathological neovascularization-related conditions |
02/15/2012 | EP2117553B8 Compositions for treating, reducing, ameliorating, or preventing infections of the ear or upper respiratory tract |
02/15/2012 | EP1601362B1 Use of diazoxide in the treatment of ischemia retinae |
02/15/2012 | CN1918127B 具有引入了取代或无取代氨基的4-吡啶基烷硫基的环状化合物 The introduction of a cyclic compound having a substituted or unsubstituted 4-pyridyl amino alkylthio |
02/15/2012 | CN102351934A Steroidal alkaloid compounds and pharmaceutical composition thereof, as well as preparation methods and applications of steroidal alkaloid compounds and pharmaceutical composition of compounds |
02/15/2012 | CN102349926A New medical application of combination of paeonol, derivative thereof and paeoniflorin |
02/15/2012 | CN102349910A Compound medicinal composition for ophthalmology and preparation method thereof |
02/15/2012 | CN102091212B 一种治疗复发性中心性浆液性脉络膜视网膜病的中药汤剂 A treatment for recurrent central serous retinopathy decoction |
02/14/2012 | US8114999 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
02/14/2012 | US8114849 Retinal dystrophy-associated protein and uses thereof |
02/14/2012 | US8114618 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays |
02/14/2012 | CA2463154C Heterocyclic compounds and methods of use |
02/14/2012 | CA2402160C Heparinase iii and uses thereof |
02/09/2012 | WO2012017077A1 Combination of compounds for treating or preventing skin diseases |
02/09/2012 | WO2012016930A1 Compound useful for the treatment of nonsense-mutation-mediated diseases and pharmaceutical composition comprising said compound |
02/09/2012 | US20120035256 Use of bipolar trans carotenoids as a pretreatment and in the treatment of peripheral vascular disease |
02/09/2012 | US20120035250 Plasmalogen compounds, pharmaceutical compositions containing the same and methods for treating diseases of the aging |
02/09/2012 | US20120035239 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
02/09/2012 | US20120035217 Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors |
02/09/2012 | US20120035214 Renin inhibitors |
02/09/2012 | US20120035207 Use of GABAA Receptor Agonists for the Treatment of Hearing, Vestibular and Attention Disorders, Intention Tremor and Restless Leg Syndrome |
02/09/2012 | US20120035187 Anti-neurodegenerative disease agent |
02/09/2012 | US20120035179 Modulators of atp-binding cassette transporters |
02/09/2012 | US20120035175 Novel salts as Anti-Inflammatory, Immunomodulatory and Anti-Proliferatory Agents |
02/09/2012 | US20120035168 N-((6-amino-pyridin-3-yl)methyl)-heteroaryl-carboxamides |
02/09/2012 | US20120035159 Substituted isoquinoline derivative |
02/09/2012 | US20120035154 Modulators of Cellular Adhesion |
02/09/2012 | US20120035150 Mif inhibitors and their uses |
02/09/2012 | US20120035148 Ophthalmic compositions and methods for treating ophthalmic conditions |
02/09/2012 | US20120035147 Method for treatment of diseases |
02/09/2012 | US20120035146 Implants and methods for treating inflammation-mediated conditions of the eye |
02/09/2012 | US20120035140 Carbamoylphosphonates as inhibitors and uses thereof |
02/09/2012 | US20120034321 Nitric oxide enhancing prostaglandin compounds, compositions and methods of use |
02/09/2012 | US20120034303 Pharmaceutical formulation comprising one or more fumaric acid esters in an erosion matrix |
02/09/2012 | US20120034279 Transscleral delivery |
02/09/2012 | US20120034274 Pharmaceutical composition comprising one or more fumaric acid esters |
02/09/2012 | US20120034201 Composition for regulating lipid metabolism |
02/09/2012 | US20120034193 Treatment of neurotrophic factor mediated disorders |
02/09/2012 | CA2810267A1 Combination of compounds for treating or preventing skin diseases |
02/09/2012 | CA2807537A1 Combined drug delivery methods and apparatus |
02/09/2012 | CA2807508A1 Subconjunctival implant for posterior segment drug delivery |
02/09/2012 | CA2807376A1 Collagen-based implants for sustained delivery of drugs |
02/09/2012 | CA2806825A1 Compound useful for the treatment of nonsense-mutation-mediated diseases and pharmaceutical composition comprising said compound |
02/08/2012 | EP2415763A1 Pharmaceutical composition for treating or preventing glaucoma |
02/08/2012 | EP2415755A1 Plasminogen activator inhibitor-1 inhibitor |
02/08/2012 | EP2415478A1 Prophylactic or therapeutic agent for retinal diseases and method for preventing or treating retinal diseases, each comprising jnk (c-jun n-terminal kinase)-inhibiting peptide, and use of the peptide |
02/08/2012 | EP2415474A1 Pharmaceutical composition for treatment or prevention of ophthalmic diseases |
02/08/2012 | EP2415468A1 Composition for alleviating ultraviolet radiation-induced damage |
02/08/2012 | EP2414330A2 Piperidine and piperazine derivatives as autotaxin inhibitors |
02/08/2012 | CN102348714A Steroid compound |
02/08/2012 | CN102348683A Prophylactic or therapeutic agent for optic nerve disorders comprising 4,6-dichloro-1h-indole-2-carboxylic acid derivative or salt thereof as active ingredient |
02/08/2012 | CN102348456A Use of deferiprone for treatment and prevention of iron-related eye disorders |
02/08/2012 | CN102344416A Pyridazine derivative and application thereof serving as anti-small RNA (Ribose Nucleic Acid) virus infection medicament |
02/08/2012 | CN102343050A Eye ointment for treating eye diseases |
02/08/2012 | CN102343040A Drug for treating otitis media, deaf and tinnitus |
02/08/2012 | CN102343030A Method for treating vitreous opacity with Chinese herbal medicines |
02/08/2012 | CN102343012A Composition for treating ophthalmic diseases and its preparation method |
02/08/2012 | CN102342982A Traditional Chinese medicine for expelling wind, improving eyesight and treating conjunctivitis and preparation method of same |
02/08/2012 | CN102342967A Thin film coated tablets containing vitamin, ginseng and zinc sulfate and preparation method thereof |
02/08/2012 | CN102342957A Powder for otitis media and preparation method thereof |
02/08/2012 | CN102342941A Ophthalmic and otic compositions of facially amphiphilic polymers and oligomers |
02/08/2012 | CN102342938A Methods and compositions for treatment and management of cancers |
02/08/2012 | CN102342925A Compositions for treating infection in cattle and swine |
02/08/2012 | CN102342911A Ganciclovir eye drops and preparation method thereof |
02/08/2012 | CN102342908A 胶原蛋白角膜 Corneal Collagen |
02/08/2012 | CN101384704B 可再吸收的角膜扣状体 Resorbable corneal button-shaped body |
02/08/2012 | CN101180082B 利用siv-pedf载体治疗伴随眼组织细胞凋亡变性的疾患的药物 Use siv-pedf vehicle treated apoptotic degeneration associated with ocular tissue disorders drug |
02/07/2012 | US8110177 Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
02/07/2012 | CA2486144C Compositions comprising an angiotensin receptor blocker, a calcium channel blocker and a diuretic |
02/07/2012 | CA2471046C Treatment of faecal incontinence and other conditions with 1r, 2s-methoxamine |
02/07/2012 | CA2452923C Peptide-based compounds for targeting integrin receptors |
02/02/2012 | WO2012016162A2 Compositions, methods and kits for modeling, diagnosing, and treating complement disorders |